243 related articles for article (PubMed ID: 29776959)
61. Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry.
Deng H; Shantsila A; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Liu Y; Wei W; Fu L; Xue Y; Wu S; Lip GYH
Arch Cardiovasc Dis; 2019 Mar; 112(3):171-179. PubMed ID: 30683618
[TBL] [Abstract][Full Text] [Related]
62. Atrial Fibrillation Complexity Parameters Derived From Surface ECGs Predict Procedural Outcome and Long-Term Follow-Up of Stepwise Catheter Ablation for Atrial Fibrillation.
Lankveld T; Zeemering S; Scherr D; Kuklik P; Hoffmann BA; Willems S; Pieske B; Haïssaguerre M; Jaïs P; Crijns HJ; Schotten U
Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003354. PubMed ID: 26823480
[TBL] [Abstract][Full Text] [Related]
63. Regional differences in referral, procedures, and outcome after ablation for atrial fibrillation in Europe: a report from the Atrial Fibrillation Ablation Pilot Registry of the European Society of Cardiology.
Riahi S; Arbelo E; Brugada J; Maggioni AP; Tavazzi L; Vardas P; Laroche C; Efremidis M; Xhaet O; Woźniak A; Van Gelder IC; Hjortshoj S
Europace; 2016 Feb; 18(2):191-200. PubMed ID: 26647447
[TBL] [Abstract][Full Text] [Related]
64. Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: A propensity score-matched analysis.
Saliba W; Schliamser JE; Lavi I; Barnett-Griness O; Gronich N; Rennert G
Heart Rhythm; 2017 May; 14(5):635-642. PubMed ID: 28189823
[TBL] [Abstract][Full Text] [Related]
65. Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial).
Lip GYH; Al-Saady N; Jin J; Sun M; Melino M; Winters SM; Zamoryakhin D; Goette A
Am J Cardiol; 2017 Sep; 120(5):792-796. PubMed ID: 28709650
[TBL] [Abstract][Full Text] [Related]
66. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
[TBL] [Abstract][Full Text] [Related]
67. The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification.
Wynn GJ; Todd DM; Webber M; Bonnett L; McShane J; Kirchhof P; Gupta D
Europace; 2014 Jul; 16(7):965-72. PubMed ID: 24534264
[TBL] [Abstract][Full Text] [Related]
68. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
[TBL] [Abstract][Full Text] [Related]
69. Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation.
Dan GA; Badila E; Weiss E; Laroche C; Boriani G; Dan A; Tavazzi L; Maggioni AP; Crijns HJ; Popescu R; Blommaert D; Streb W; Lip GYH;
Int J Cardiol; 2018 Mar; 254():136-141. PubMed ID: 29407080
[TBL] [Abstract][Full Text] [Related]
70. Atrial fibrillation patients with CHA2DS2-VASc >1 benefit from oral anticoagulation prior to cardioversion.
Själander S; Svensson PJ; Friberg L
Int J Cardiol; 2016 Jul; 215():360-3. PubMed ID: 27128562
[TBL] [Abstract][Full Text] [Related]
71. Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure.
Sandhu RK; Hohnloser SH; Pfeffer MA; Yuan F; Hart RG; Yusuf S; Connolly SJ; McAlister FA; Healey JS
Stroke; 2015 Mar; 46(3):667-72. PubMed ID: 25628308
[TBL] [Abstract][Full Text] [Related]
72. Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation.
Li S; Zhao X; Wang C; Liu L; Liu G; Wang Y; Wang C; Jing J; Wang YJ
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e419-25. PubMed ID: 23721617
[TBL] [Abstract][Full Text] [Related]
73. Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry.
Jackson LR; Kim SH; Piccini JP; Gersh BJ; Naccarelli GV; Reiffel JA; Freeman J; Thomas L; Chang P; Fonarow GC; Go AS; Mahaffey KW; Peterson ED; Kowey PR
Clin Cardiol; 2016 Feb; 39(2):119-25. PubMed ID: 26720750
[TBL] [Abstract][Full Text] [Related]
74. Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation.
Nairooz R; Sardar P; Pino M; Aronow WS; Sewani A; Mukherjee D; Paydak H; Maskoun W
Int J Cardiol; 2015; 187():345-53. PubMed ID: 25839640
[TBL] [Abstract][Full Text] [Related]
75. [The immediate and long-term efficacy of electrical cardioversion in atrial fibrillation].
Frabetti L; Carioli E; Antonioli P; Ferrari G; Magnani B
Cardiologia; 1993 Sep; 38(9):561-7. PubMed ID: 8287385
[TBL] [Abstract][Full Text] [Related]
76. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
77. Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation.
Gersak B; Pernat A; Robic B; Sinkovec M
J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1059-66. PubMed ID: 22587585
[TBL] [Abstract][Full Text] [Related]
78. Efficacy of Oral Anticoagulation in Stroke Prevention among Sinus-Rhythm Patients Who Lack Left Atrial Mechanical Contraction after Cryoablation.
Martínez-Comendador J; Gualis J; Marcos-Vidal JM; Buber J; Martín CE; Gomez-Plana J; Rodríguez MA; Iglesias-Garriz I; Alonso D; Soria C; Miguélez EH; Castaño M
Tex Heart Inst J; 2015 Oct; 42(5):430-7. PubMed ID: 26504435
[TBL] [Abstract][Full Text] [Related]
79. [Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation].
Potpara T; Marinković-Erić J; Grujić M; Radojković-Cirović B; Vujisić-Tesić B; Petrović M
Srp Arh Celok Lek; 2002; 130(5-6):189-92. PubMed ID: 12395441
[TBL] [Abstract][Full Text] [Related]
80. Management and 1-year outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events.
Zubaid M; Rashed WA; Alsheikh-Ali AA; Al-Zakwani I; AlMahmeed W; Shehab A; Sulaiman K; Qudaimi AA; Asaad N; Amin H;
Angiology; 2015 May; 66(5):464-71. PubMed ID: 24904179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
